| Normal-weight (n = 131) | Overweight (n = 132) | Obese (n = 142) | P-value |
---|---|---|---|---|
Age | Â | Â | Â | 0.031 |
 <40 years | 0.15 | 0.11 | 0.06 |  |
 40–49 years | 0.27 | 0.20 | 0.22 |  |
 ≥50 years | 0.58 | 0.69 | 0.72 |  |
Ethnicity | Â | Â | Â | 0.031 |
 African American | 0.17 | 0.19 | 0.32 |  |
 Asian | 0.04 | 0.02 | 0.01 |  |
 Hispanic | 0.02 | 0.02 | 0.01 |  |
 Other | 0.01 | 0.02 | 0.01 |  |
 Non-Hispanic White | 0.76 | 0.75 | 0.65 |  |
Tumor Size | Â | Â | Â | 0.130 |
 T1 | 0.59 | 0.56 | 0.50 |  |
 T2 | 0.35 | 0.34 | 0.45 |  |
 T3 | 0.06 | 0.10 | 0.05 |  |
Tumor Grade | Â | Â | Â | 0.216 |
 Well (Grade 1) | 0.23 | 0.21 | 0.19 |  |
 Moderate (Grade 2) | 0.42 | 0.35 | 0.32 |  |
 Poor (Grade 3) | 0.35 | 0.44 | 0.49 |  |
Intrinsic Subtype | Â | Â | Â | 0.560 |
 Luminal A | 0.52 | 0.48 | 0.54 |  |
 Luminal B | 0.13 | 0.08 | 0.11 |  |
 HER2-enriched | 0.11 | 0.16 | 0.08 |  |
 Basal-like | 0.23 | 0.27 | 0.24 |  |
 Normal-like | 0.01 | 0.01 | 0.03 |  |
Lymph Node Status | Â | Â | Â | 0.447 |
 Positive | 0.36 | 0.40 | 0.44 |  |
 Negative | 0.64 | 0.60 | 0.56 |  |
TNM Stage | Â | Â | Â | 0.144 |
 Stage I | 0.45 | 0.40 | 0.31 |  |
 Stage II | 0.41 | 0.42 | 0.48 |  |
 Stage III | 0.12 | 0.12 | 0.18 |  |
 Stage IV | 0.02 | 0.06 | 0.03 |  |
Statusa | Â | Â | Â | 0.929 |
 Died of disease | 0.08 | 0.07 | 0.07 |  |
 Died other causes | 0.02 | 0.03 | 0.02 |  |
 Alive with disease | 0.05 | 0.05 | 0.03 |  |
 Alive, disease-free | 0.85 | 0.85 | 0.88 |  |